Xender to distribute 10,000 CyberCare systemsXender Corporation, a Taiwanese electronic instruments manufacturer, has signed a licensing agreement with CyberCare, a technology-based health management company, to manufacture, sell, and distribute
Xender Corporation, a Taiwanese electronic instruments manufacturer, has signed a licensing agreement with CyberCare, a technology-based health management company, to manufacture, sell, and distribute 10,000 CyberCare Electronic HouseCall systems over the next three years. Under terms of the deal, Xender will pay CyberCare a $500 per unit royalty fee to install, operate, and maintain the communications network in Taiwan and will receive a recurring network fee of $200 per month per installed unit.
Xender claims to have established relationships with more than 300 medical facilities in Taiwan and expects these customers to purchase the Electronic HouseCall system to enhance care for their chronically ill patients. The Electronic HouseCall is an Internet-based system for remote monitoring of patients.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.